Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 22.83 CNY 0.35% Market Closed
Market Cap: 7B CNY

Sirio Pharma Co Ltd
Cost of Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sirio Pharma Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cost of Revenue
-ÂĄ3B
CAGR 3-Years
-22%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cost of Revenue
-ÂĄ15.4B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Proya Cosmetics Co Ltd
SSE:603605
Cost of Revenue
-ÂĄ3B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cost of Revenue
-ÂĄ2.3B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
-15%
S
Shanghai Chicmax Cosmetic Co Ltd
HKEX:2145
Cost of Revenue
-ÂĄ1.7B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cost of Revenue
-ÂĄ991.9m
CAGR 3-Years
-71%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
25.66 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Cost of Revenue?
Cost of Revenue
-3B CNY

Based on the financial report for Sep 30, 2025, Sirio Pharma Co Ltd's Cost of Revenue amounts to -3B CNY.

What is Sirio Pharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for Sirio Pharma Co Ltd have been -22% over the past three years , -19% over the past five years .

Back to Top